Clinical Trial Update: Advanced MRI Measures of Repair in Alemtuzumab Treated Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting advanced MRI measures of repair in alemtuzumab-treated patients with relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: University of British Columbia | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 3 | Status: COMPLETED